期刊文献+

末端带叶酸的星形聚己内酯的合成及表征 被引量:2

Synthesis and characterization of star-shaped poly(ε-caprolactone) with end group folates
在线阅读 下载PDF
导出
摘要 用1,1,1-三羟甲基乙烷及2,2-二羟甲基丙酸为原料合成了树型分子R(CH2OH)6;然后以此树形分子引发ε-己内酯开环聚合,得到了六臂星形聚己内酯(Star PCL);再通过DCC使叶酸与星形聚己内酯各臂链端的羟基官反应,得到了链端接枝叶酸的星形聚己内酯(StarPCL-FA)。1H-NMR和FT-IR确证了产物的结构。结果表明,成功地制备了六臂星形聚己内酯-叶酸材料,它们有望成为一类新型的肿瘤靶向药物载体材料。 Star-shaped poly(ε-caprolactone)s(Star PCLs) with six arms were successfully synthesized via ring-opening polymerization of ε-caprolactone initiated by a dendrimer which was synthesized by TME and 2,2-bishydroxymethylepropanoic acid.Then by conjugating the end hydroxyl groups of Star PCLs with the carboxyl groups of folic acid,star-shaped poly(ε-caprolactone)s with folates(Star PCL-FAs) were obtained.Characterizations of these materials by 1H-NMR,FT-IR were carried out.The results showed that the arm number of the Star PCLs was in accordance with the hydroxyl group number of the initiator and the conjugation of folic acid was successful.These polymers are expected to be used as drug carriers for targeted drug delivery.
出处 《功能材料》 EI CAS CSCD 北大核心 2010年第2期222-224,共3页 Journal of Functional Materials
基金 国家自然科学基金资助项目(50873065) 国际科技合作重点资助项目(2006DFA53470)
关键词 星形聚合物 聚己内酯 叶酸 药物载体 star-shaped polymer PCL folic acid drug carrier materials
  • 相关文献

参考文献1

二级参考文献8

  • 1Zhao Y M,Wang Z Y,Wang J,et al. [J]. J Appl Polym Sci, 2004,91 (4) : 2143-2150.
  • 2Zhao Y M,Wang Z Y,Yang F. [J].J Appl Polym Sci, 2005,97(1) :195-200.
  • 3Nagasaki Y, Okada T, Scholz C. [J]. Macromo lecules, 1998,31: 1473-1479.
  • 4Cook A D, Rkach J S,Gao N N. [J]. Biomed Mater Res, 1997,35:513-52.
  • 5Leamon C P. [J]. DDT,2001,6(1):44-51.
  • 6Weitman S D. [J]. Cancer Res, 1992,52 (12) : 3396-3401.
  • 7Stahl G L,Walter R. [J]. Org Chem, 1978,43:2285.
  • 8Schneider R, Sehmitt F. [J]. Bioorg Med Chem, 2005,13: 2799-2808.

共引文献5

同被引文献19

  • 1张国林,马建标,王亦农.两亲聚L-丙氨酸-聚乙二醇单甲醚嵌段共聚物的合成及表征[J].高分子材料科学与工程,2006,22(3):50-53. 被引量:2
  • 2苟马玲,张阳德,王辉,谢震,王吉伟,潘一峰,谢希惠,涂铭旌,钱志勇.一种聚己内酯-聚乙二醇-聚己内酯磁性共聚物微球的制备[J].高分子材料科学与工程,2007,23(4):235-237. 被引量:6
  • 3van Dongen S F M, de Hoog H M, Peters R J R W. [J]. Chem Rev, 2009, 109(11): 6212.
  • 4Yokoyama M. [J]. Export Opinion on Drug Delivery, 2010, 7(2): 145.
  • 5Mikhail A S, Allen C.[J].J Control Release, 2009, 138 (3) : 214.
  • 6Lee E S, Gao Z, Bae Y H. [J]. J Control Release, 2008, 132(3): 164.
  • 7Zhang Y, Guo L, Roeske R W, et al. [J].Anal Biochem, 2004, 332: 168.
  • 8Sudimack J, Lee R J. [J].Adv Drug Delivery Rev, 2000, 41(2):147.
  • 9Pan J, Feng S.[J]. Biomater, 2008, 29: 2663.
  • 10Park E K, Kim S Y, Lee S B, et al. [J]. J Control Release, 2005, 109:158.

引证文献2

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部